EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reversible Metabolic and Liver Disease in Complex III Deficiency: Novel Variants Expand the Reported UQCRC2-Associated Phenotype

Graeme Preston iD, Ibrahim Shammas iD, Filippo Pinto E Vairo iD, Anna Ligezka, Carlos Alberto de Moura Aschoff iD, Fabiano Poswar iD, Ida Vanessa D Schwartz, Tamas Kozicz, Eva Morava iD

Cells · 27.03.2026 · 15 (7) · 596

DOI: 10.3390/cells15070596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 27.03.2026. Verfasst von Graeme Preston und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genomics, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Electron Transport Complex III, Mitochondrial Diseases, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian Rare Genome Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ubiquinol–cytochrome c reductase core protein II (UQCRC2) encodes a core subunit of the mitochondrial electron transport chain (ETC) complex III (CIII). Biallelic pathogenic variants in UQCRC2 have been associated with mitochondrial disease characterized by lactic acidosis, developmental delay, hepatopathy, and episodic metabolic decompensation.

Methods

We reviewed the biochemical phenotypes of 14 individuals possessing UQCRC2 variants, including two novel cases. We performed biochemical studies of mitochondrial respiration and oxidative phosphorylation (OXPHOS) complex measurements in patient-derived fibroblasts.

Results

We report reduced CIII activity in a majority of individuals possessing variants in UQCRC2, as well as biochemical findings consistent with impaired mitochondrial energy metabolism, though impairments in mitochondrial respiration were variable. The two previously unreported, unrelated patients possessing the likely pathogenic missense variant c.361T>C, p.Tyr121His in UQCRC2 in trans with a 16p12.2 microdeletion encompassing UQCRC2 showed milder phenotypes, less severe metabolic decompensations, and no long-term neurological impairments. Both individuals display reduced CIII activity and mitochondrial respiratory dysfunction.

Discussion

These data expand the current understanding of genotypes associated with UQCRC2-associated mitochondrial disease to include the novel 16p12.2 microdeletion. These data also highlight the consistent biochemical phenotype associated with UQCRC2-associated mitochondrial disease, and the need for consistent biochemical and respiratory assessment of individuals possessing UQCRC2 variants to further our understanding of this phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electron Transport Complex IIIMitochondrial DiseasesLiver DiseasesHumansPhenotypeFemaleMitochondriaOxidative PhosphorylationMaleFibroblastsChild, PreschoolChildMutation

Stichwörter der Autor:innen

OXPHOSSeahorsecomplex IIIhyperammonemiamicrodeletion 16p12.2mitochondrial

Substanzen

Electron Transport Complex III

Autor:innen und Institutionen

  • Department of Clinical Genomics, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, New York, NY 10029, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA.
  • Post Graduate Program in Genetics and Molecular Biology, Federal University of Rio Grande do Sul, Avenida Osvaldo Aranha, 338, Porto Alegre 90040-060, RS, Brazil.
  • Medical Genetics Service, Hospital de Clinicas de Porto Alegre, Rua Ramiro Barcelos 2350, Porto Alegre 90035-003, RS, Brazil.
  • Department of Anatomy, University of Pecs Medical School, Pecs Szigeti út, 12 7624 Pecs, Hungary.

ORCID-Profile: Graeme Preston, Ibrahim Shammas, Filippo Pinto E Vairo, Carlos Alberto de Moura Aschoff, Fabiano Poswar, Eva Morava

Förderung

  • Brazilian Rare Genome Project

Zitieren

APA

Preston, G., Shammas, I., Pinto E Vairo, F., Ligezka, A., Aschoff, C. A. M., Poswar, F., Schwartz, I. V. D., Kozicz, T., & Morava, E. (2026). Reversible Metabolic and Liver Disease in Complex III Deficiency: Novel Variants Expand the Reported UQCRC2-Associated Phenotype. Cells, 15(7), 596. https://doi.org/10.3390/cells15070596

Vancouver

Preston G, Shammas I, Pinto E Vairo F, Ligezka A, Aschoff CAM, Poswar F, et al. Reversible Metabolic and Liver Disease in Complex III Deficiency: Novel Variants Expand the Reported UQCRC2-Associated Phenotype. Cells. 2026;15(7):596. doi:10.3390/cells15070596

BibTeX
@article{Preston2026,
  author = {Preston, Graeme and Shammas, Ibrahim and Pinto E Vairo, Filippo and Ligezka, Anna and Aschoff, Carlos Alberto de Moura and Poswar, Fabiano and Schwartz, Ida Vanessa D and Kozicz, Tamas and Morava, Eva},
  title = {Reversible Metabolic and Liver Disease in Complex III Deficiency: Novel Variants Expand the Reported UQCRC2-Associated Phenotype},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {596},
  doi = {10.3390/cells15070596}
}
Kostenlos starten →